AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-5.11%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$10.4B
AUM Growth
-$929M
(-8.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
43.03%
Holding
1,068
New
166
Increased
266
Reduced
450
Closed
162
Top Buys
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$46.4M |
| 2 |
Stem
STEM
|
$28.4M |
| 3 |
Plains All American Pipeline
PAA
|
$21.2M |
| 4 |
Evercore
EVR
|
$16.7M |
| 5 |
Green Plains
GPRE
|
$15.8M |
Top Sells
| 1 |
MPLX
MPLX
|
$69.9M |
| 2 |
Universal Display
OLED
|
$47.2M |
| 3 |
Acuity Brands
AYI
|
$44.9M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$40.6M |
| 5 |
Western Midstream Partners
WES
|
$39.1M |
Sector Composition
| 1 | Energy | 50.72% |
| 2 | Financials | 11.42% |
| 3 | Technology | 6.62% |
| 4 | Healthcare | 4.85% |
| 5 | Consumer Discretionary | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Motorola Solutions
MSI
$79.8B
| $1.91M | 0.02% |
8,199
+2,299
| +39% | +$534K |
|
327
Atara Biotherapeutics
ATRA
$90.7M
| $1.86M | 0.02% |
4,155
-274
| -6% | -$123K |
|
|
KDMN
328
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.85M | 0.02% |
212,448
-14,067
| -6% | -$122K |
|
329
Inovio Pharmaceuticals
INO
$148M
| $1.85M | 0.02% |
21,486
-1,349
| -6% | -$116K |
|
330
McEwen Inc.
MUX
$734M
| $1.83M | 0.02% |
175,816
+9,350
| +6% | +$97.2K |
|
331
Travere Therapeutics
TVTX
$1.93B
| $1.8M | 0.02% |
74,411
-5,214
| -7% | -$126K |
|
332
News Corp Class B
NWS
$18.8B
| $1.72M | 0.02% |
74,186
| – | – |
|
333
Progressive
PGR
$143B
| $1.71M | 0.02% |
18,873
-1,470
| -7% | -$133K |
|
334
Replimune Group
REPL
$494M
| $1.7M | 0.02% |
57,322
-4,065
| -7% | -$120K |
|
335
Alphabet (Google) Class A
GOOGL
$2.84T
| $1.67M | 0.02% |
12,500
-1,780
| -12% | -$238K |
|
336
StepStone Group
STEP
$4.78B
| $1.66M | 0.02% |
39,000
-10,100
| -21% | -$431K |
|
337
Zymeworks
ZYME
$1.14B
| $1.65M | 0.02% |
56,851
-3,562
| -6% | -$103K |
|
338
Prologis
PLD
$105B
| $1.64M | 0.02% |
13,059
-1,060
| -8% | -$133K |
|
339
Domino's
DPZ
$15.7B
| $1.64M | 0.02% |
3,427
-190
| -5% | -$90.6K |
|
340
Madrigal Pharmaceuticals
MDGL
$9.65B
| $1.62M | 0.02% |
20,338
-1,406
| -6% | -$112K |
|
341
UnitedHealth
UNH
$286B
| $1.62M | 0.02% |
4,146
-300
| -7% | -$117K |
|
342
Sangamo Therapeutics
SGMO
$165M
| $1.61M | 0.02% |
178,133
-11,385
| -6% | -$103K |
|
343
Starbucks
SBUX
$97.1B
| $1.6M | 0.02% |
14,460
+590
| +4% | +$65.1K |
|
|
BLUE
344
DELISTED
bluebird bio
BLUE
| $1.58M | 0.02% |
6,395
-425
| -6% | -$105K |
|
345
MacroGenics
MGNX
$126M
| $1.57M | 0.02% |
74,897
-4,180
| -5% | -$87.5K |
|
346
Arcturus Therapeutics
ARCT
$485M
| $1.54M | 0.01% |
32,259
-2,406
| -7% | -$115K |
|
347
Y-mAbs Therapeutics
YMAB
$390M
| $1.52M | 0.01% |
53,409
-3,977
| -7% | -$113K |
|
|
PDM
348
Piedmont Realty Trust, Inc.
PDM
$1.09B
| $1.52M | 0.01% |
87,041
-3,685
| -4% | -$64.2K |
|
349
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.51M | 0.01% |
93,732
-6,038
| -6% | -$97K |
|
350
Arcutis Biotherapeutics
ARQT
$2.06B
| $1.47M | 0.01% |
61,578
-4,546
| -7% | -$109K |
|